30 Day Trial

Biologics4Life Secures License to Bone Tissue Regeneration Technology

Biologics4Life completed an exclusive licensing agreement to secure rights to initial technologies for bone tissue regeneration.

EnMovi Formed to Develop Wearable/Data Analytics Tool for Orthopedic Procedures

OrthoSensor and McLaren Applied formed EnMovi to expand development of MOTIONSENSE™ wearable sensor technology and ORTHOLOGIQ® data analytics for use in orthopedic patient care.

Cutting Edge Spine Gains FDA Clearance of EVOLha-DLIF

Cutting Edge Spine received FDA 510(k) clearance of the EVOL®ha-DLIF direct lateral interbody fusion system.

Silver Bullet Therapeutics Gains CE Mark for OrthoFuzIon Bone Screw

Silver Bullet Therapeutics received CE Mark approval for the OrthoFuzIon™ Bone Screw for reduction and internal fixation procedures anywhere in the body.

Royal Biologics Launches MAGNUS DMSO-Free Viable Cellular Bone Allograft

Royal Biologics launched MAGNUS, a viable cellular bone allograft that uses a DMSO-free cryoprotectant.

Episurf Medical receives CE Mark for Episealer Talus and Talus Osteotomy Guide

Episurf Medical received approval under the CE Mark for the Episealer® Talus and Talus Osteotomy Guide.

Carmell Therapeutics Gains IND Application Clearance for Bone Healing Accelerant

Carmell Therapeutics announced FDA clearance of an Investigational New Drug application for the company’s Bone Healing Accelerant and enrollment in a pivotal study for long bone fractures.

Medtronic Releases Field Safety Notice for Mazor X

Medtronic issued an urgent field safety notice regarding the potential for the Mazor X Surgical System with Positioner Type II to detach from the O.R. table unexpectedly.

Bone Biologics Study Shows Bone Formation in Spine Model

Preclinical animal study results indicate that Bone Biologics' rhNELL-1 growth factor effectively promoted bone formation in a spine model. 

Exactech Names New CEO, Darin Johnson

Exactech appointed Mr. Darin Johnson as President and Chief Executive Officer, successor of Mr. David Petty, who will transition from CEO to Vice Chairman of the company's board of directors. Co-founders Bill Petty, M.D. and Betty Petty are retiring after 35 years at the company.


It's important to know that ORTHOFLASH (like many ORTHOWORLD resources) is included with Membership. The full menu of Membership benefits is outlined on this pageStill have questions? Or, would you prefer personal attention?
Fran Bursic welcomes your inquiry by phone at 440.543.2101 or via 

Read more from ORTHOWORLD: